Compare BIPC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIPC | STVN |
|---|---|---|
| Founded | 2019 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.5B |
| IPO Year | 2019 | 2021 |
| Metric | BIPC | STVN |
|---|---|---|
| Price | $40.27 | $21.21 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $45.00 | $25.67 |
| AVG Volume (30 Days) | ★ 1.1M | 398.6K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.13% | 0.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.85 | $9.67 |
| Revenue Next Year | $5.94 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.18 | $12.89 |
| 52 Week High | $51.72 | $28.00 |
| Indicator | BIPC | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 62.91 |
| Support Level | $40.03 | $20.34 |
| Resistance Level | $42.84 | $22.00 |
| Average True Range (ATR) | 1.41 | 0.82 |
| MACD | -0.12 | 0.08 |
| Stochastic Oscillator | 29.52 | 84.67 |
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.